Serosafe: Dubilier Grand Prize Winner, Rock Business Track, 2026 New Venture Competition @HarvardHBS
Serosafe: Dubilier Grand Prize Winner, Rock Business Track, 2026 New Venture Competition  @HarvardHBS
Uploaded March 2026 | Updated November 2026, 3 hours ago
Serosafe is a clinical stage medical technology startup developing medical devices that prevent pain and complications associated with post-operative surgical drains. Team: Goutam Gadiraju (MBA 2026), Justin Broyles (MPH 2026).
Serosafe: Dubilier Grand Prize Winner, Rock Business Track, 2026 New Venture CompetitionLabor in a Changing Climate | Harvard Business School x Probable FuturesSustainable Mining – Making 200,000 Tons of CO₂ DisappearDean Srikant Datar’s 2026 Commencement AddressClimate Rising: Closing the Loop by Recycling Apparel with ReJu CEO Patrik FriskHow Inequality Hurts the Market — and What Investors Can Do About It | Columbia Professor ExplainsClimate Rising: How IKEA Designs for Circularity with Chief Sustainability Officer Karen PflugHBS Alumni Careers | Lindsay Muller (MBA 2024)Welcome to the MBA Class of 2028CEO of Tree Energy Solutions: Why Shell & Mitsubishi Bet on the Only Affordable E-FuelFeaturing The Parlor Room Presents: Hello AI: Linda Hill on Leading Through AI-Driven Change2026 Class Day Welcome Co Chairs Riddhi Sangam and Jess Williams
Harvard Business School |

Serosafe: Dubilier Grand Prize Winner, Rock Business Track, 2026 New Venture Competition

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER